A carregar...
Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer
PURPOSE: Chemotherapy induced ovarian failure (CIOF) results in rapid bone loss. Receptor Activator of Nuclear Factor Kappa-B (RANK)-RANK ligand (RANK-L) signaling balances bone resorption and formation. Osteoprotegerin (OPG) acts as a decoy receptor for RANK, interrupting osteoclast activation and...
Na minha lista:
| Publicado no: | Mol Cell Endocrinol |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4316829/ https://ncbi.nlm.nih.gov/pubmed/25575458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mce.2014.12.028 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|